Author

Mark Woodnorth

Broad Institute

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:spatial transcriptomics· 1 Approach:statistical model· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

Anne ZarembaiD· 1 shared Antje SuckeriD· 1 shared Bastian SchillingiD· 1 shared Bojan KarlašiD· 1 shared Carola BerkingiD· 1 shared Christine Guo LianiD· 1 shared David LiuiD· 1 shared Dirk SchadendorfiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anne ZarembaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Multiomic profiling of a unique in-transit melanoma cohort identifies melanoma differentiation as predictor of tumor progression and therapy response

Giuseppe Tarantino, Anne Zaremba, Tuulia Vallius, Mark Woodnorth, Yichao Hua, Roxanne J. Pelletier, Mariana Lopez Leon, Yingxiao Shi, Zoltan Maliga, Samira Makhzami, Tyler J. Aprati, Bojan Karlaš, Valerie Glutsch, Bastian Schilling, Jessica C. Hassel, , Dirk Schadendorf

The paper identifies melanoma differentiation and immune exhaustion as predictors of tumor progression and therapy response in in-transit melanoma patients through multiomic profiling.

bioRxiv · Oct 1, 2025 · PreprintCancer Biology